Project Grant R01NS135206

Award Date 7/1/24
Completion Date 6/30/29
Dollars Obligated $1.6M
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Syracuse, NY 13210, USA
Similar Awards
This $458,189 Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, funds research to investigate the role of membrane-remodeling factors in regulating oligodendrocyte morphology and myelination in the central nervous system. The research aims to: (1) identify the expression and sufficiency of membrane-remodeling factors in...
This $599,204 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the cellular mechanisms driving learning-induced myelin remodeling and its role in motor learning. The primary awardee, The Leland Stanford Junior University, will conduct experiments to determine whether oligodendrocyte calcium signaling is...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $563,343 Project Grant (R01NS140233) to New York University School of Medicine under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant supports research focused on understanding how tissues move and split to form neural cell clusters and layers during nervous system development. The researchers aim to use the zebrafish posterior lateral...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $352,073 to support research on using an ABCA1 cholesterol transporter agonist to correct pathophysiological myelin formation in hereditary neuropathies. The research aims to advance a novel candidate drug for restoring functional cholesterol access and supporting myelin...
This $145,642 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate mRNA regulation during synaptogenesis in the nematode C. elegans. The study will leverage high-resolution imaging and mass spectrometry techniques to characterize the dynamics of the essential presynaptic gene syd-2/liprin-alpha and identify novel...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $397,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to the Massachusetts Institute of Technology (MIT). The grant, effective May 1, 2025 through April 30, 2030, will support innovative research to study fundamental principles linking neurodevelopmental processes to the functional organization of neural circuits. The goal is to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,341,874.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research focused on three key areas: 1) elucidating the mechanisms that control dendrite development, 2) studying mechanosensation exhibited by Drosophila dendritic arborization...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,282,359.00 to the Regents of the University of Michigan to conduct research on the regulation of intermediate progenitor cells during neural development. The project aims to define the mechanisms that control the competency of neural stem cells to generate intermediate...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $667,644 to the Icahn School of Medicine at Mount Sinai to conduct research on cortical demyelination and repair in early multiple sclerosis (MS). The 5-year project aims to further the understanding of MS cortical lesion formation and repair, the underlying immunological...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded The Ohio State University a $119,018 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders program. This grant will support research into strategies to interrogate and enhance myelin remodeling in distal tissue after spinal cord injury. The goal of the NINDS program is to fund basic and applied research exploring the brain, nervous system structure...

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,550,682 to The Research Foundation For The State University Of New York to conduct research on mechanisms controlling central nervous system (CNS) myelin sheath length. The research aims to identify developmental processes that regulate myelin formation and determine how axon diameter serves as a primary instructive cue for establishing myelin sheath length. The project will leverage primary oligodendrocyte-microfiber cultures, ex vivo slice cultures, and in vivo tissue analysis to investigate how oligodendrocyte mechanotransduction, calcium signaling, and translational regulation coordinate myelin sheath growth. Findings from this 5-year project, which began on July 1, 2024, are expected to inform strategies for restoring proper myelin architecture in neurological disorders.

Generated 6/17/25, 5:59 AM